Accordingly, the AURKs, in particular AURKA and B were proposed as promising targets for cancer therapy, e.g. in lung cancer treatment (Galetta and Cortes-Dericks, 2020), where AURK inhibition is currently evaluated in clinical trials. The gene discussed is AURKA; the disease is cancer.